American Gastroenterological Association’s NASH Clinical Care Pathway app is for use in any setting where health care professionals care for patients with NAFLD and NASH, including primary care, endocrine, obesity medicine and gastroenterology practices.

Developed with support by independent medical education grants from Intercept Pharmaceuticals, Inc., Pfizer Inc., Allergan, and Genfit.

For more information visit NASH.gastro.org.